(Q47860850)

English

Postmenopausal dehydroepiandrosterone administration increases free insulin-like growth factor-I and decreases high-density lipoprotein: a six-month trial

scientific article published in July 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/9660430

Postmenopausal dehydroepiandrosterone administration increases free insulin-like growth factor-I and decreases high-density lipoprotein: a six-month trial (English)

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/9660430

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Casson PR

1

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/9660430

Santoro N

2

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/9660430

Elkind-Hirsch K

3

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/9660430

Carson SA

4

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/9660430

Hornsby PJ

5

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/9660430

Abraham G

6

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/9660430

Buster JE

7

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/9660430

language of work or name

0 references

publication date

1 July 1998

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/9660430

Fertility and Sterility

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/9660430

70

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/9660430

1

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/9660430

107-110

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/9660430

Oral dehydroepiandrosterone in physiologic doses modulates immune function in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2898%2900121-6

7 January 2021

Reduction of atherosclerosis by administration of dehydroepiandrosterone. A study in the hypercholesterolemic New Zealand white rabbit with aortic intimal injury

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2898%2900121-6

7 January 2021

Dehydroepiandrosterone sulfate improves memory in aging mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2898%2900121-6

7 January 2021

Postmenopausal steroid replacement with micronized dehydroepiandrosterone: preliminary oral bioavailability and dose proportionality studies

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2898%2900121-6

7 January 2021

Replacement of dehydroepiandrosterone enhances T-lymphocyte insulin binding in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2898%2900121-6

7 January 2021

Delivery of dehydroepiandrosterone to premenopausal women: Effects of micronization and nonoral administration

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2898%2900121-6

7 January 2021

Identifiers

10.1016/S0015-0282(98)00121-6

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/9660430

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/9660430

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47860850&oldid=2173007035"